Current understanding of AD pathophysiology and impact of amyloid‐beta targeted treatments on biomarkers and clinical endpoints

by Ronald C. Petersen, Ana Graf, Maria C. Carrillo, Christopher J. Weber
Published 2022-01-01

Expanding Representation of Low and Middle Income Countries in Global Dementia Research: Commentary From the Alzheimer's Association

by Claire Sexton, Heather M. Snyder, Lakshmi Chandrasekaran, Susan Worley, Maria C. Carrillo
Published 2021-03-01

Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations

by Ronald C. Petersen, Ana Graf, Chris Brady, Susan De Santi, Hana Florian, Jaren Landen, Mike Pontecorvo, Christopher Randolph, Kaycee M. Sink, Maria C. Carrillo, Christopher J. Weber
Published 2023-10-01

Decision making in clinical trials: Interim analyses, innovative design, and biomarkers

by Kathleen A. Welsh‐Bohmer, Geoffrey A. Kerchner, Shobha Dhadda, Miguel Garcia, David S. Miller, Fanni Natanegara, Lars Lau Raket, Weining Robieson, Eric R. Siemers, Maria C. Carrillo, Christopher J. Weber
Published 2023-10-01

The pathway to secondary prevention of Alzheimer's disease

by Eric McDade, Martin M. Bednar, H. Robert Brashear, David S. Miller, Paul Maruff, Christopher Randolph, Zahinoor Ismail, Maria C. Carrillo, Christopher J. Weber, Lisa J. Bain, Ann Marie Hake
Published 2020-01-01

rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data

by Leonardo Iaccarino, Renaud La Joie, Robert Koeppe, Barry A. Siegel, Bruce E. Hillner, Constantine Gatsonis, Rachel A. Whitmer, Maria C. Carrillo, Charles Apgar, Monica R. Camacho, Rachel Nosheny, Gil D. Rabinovici
Published 2022-02-01

Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease

by Stacie Weninger, Bjorn Sperling, Robert Alexander, Magnus Ivarsson, Fiona M. Menzies, Peter Powchik, Christopher J. Weber, C. Anthony Altar, Ronald G. Crystal, Stephen J. Haggarty, Jeanne Loring, Lisa J. Bain, Maria C. Carrillo
Published 2020-01-01

Advancing combination therapy for Alzheimer's disease

by Stephen P. Salloway, Jeff Sevingy, Kumar Budur, Jan Torleif Pederson, Ronald B. DeMattos, Philipp Von Rosenstiel, Antonio Paez, Rebecca Evans, Christopher J. Weber, James A. Hendrix, Susan Worley, Lisa J. Bain, Maria C. Carrillo
Published 2020-01-01

Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank

by Michael P. Vitek, Joseph A. Araujo, Michael Fossel, Barry D. Greenberg, Gareth R. Howell, Stacey J. Sukoff Rizzo, Nicholas T. Seyfried, Andrea J. Tenner, Paul R. Territo, Manfred Windisch, Lisa J. Bain, April Ross, Maria C. Carrillo, Bruce T. Lamb, Rebecca M. Edelmayer
Published 2020-01-01

Building clinically relevant outcomes across the Alzheimer's disease spectrum

by Dorene M. Rentz, Alette M. Wessels, Ananth V. Annapragada, Anna‐Karin Berger, Chris J. Edgar, Michael Gold, David S. Miller, Christopher Randolph, J. Michael Ryan, Glen Wunderlich, Megan Canniere Zoschg, Dominic Trépel, David S. Knopman, Adam M. Staffaroni, Lisa J. Bain, Maria C. Carrillo, Christopher J. Weber
Published 2021-01-01

The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives

by Christopher J. Weber, Maria C. Carrillo, William Jagust, Clifford R. Jack Jr, Leslie M. Shaw, John Q. Trojanowski, Andrew J. Saykin, Laurel A. Beckett, Cyrille Sur, Naren P. Rao, Patricio Chrem Mendez, Sandra E. Black, Kuncheng Li, Takeshi Iwatsubo, Chiung‐Chih Chang, Ana Luisa Sosa, Christopher C. Rowe, Richard J. Perrin, John C. Morris, Amanda M.B. Healan, Stephen E. Hall, Michael W. Weiner
Published 2021-01-01